High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 839-840

  Rick, Oliver ^a   Siegert, Wolfgang ^a   Beyer, Jörg ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; THIOTEPA;

BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MEGADOSE; GERM CELL TUMOR; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CARBOPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ETOPOSIDE; GERMANY; GERMINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PROGNOSIS; RECURRENCE; SALVAGE THERAPY; SURVIVAL RATE; TESTICULAR NEOPLASMS; THIOTEPA;

EID: 0032735609     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991210)83:6<839::AID-IJC26>3.0.CO;2-A     Document Type: Conference Paper

References (9)

1. BEYER, J., BOKEMEYER, C., RICK, O., METZNER, B., CASPER, J., WANDT, H., HARTMANN, F., SCHMOLL, H.J., KANZ, L., HUHN, D. and SIEGERT, W., Salvage treatment in germ-cell tumors using taxol, ifosfamide, cisplatin (TIP) followed by high-dose carboplatin, etoposide and thiotepa: first results. Proc. Amer. Soc. clin. Oncol., 17, 322a (1998).
2. BEYER, J., KINGREEN, D., KRAUSE, M., SCHLEICHER, J., SCHWANER, I., SCHWELLA, N., HUHN, D. and SIEGERT, W., Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer, 79, 161-168 (1997).
3. BEYER, J. AND 12 OTHERS, High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic factors. J. clin. Oncol., 14, 2638-2645 (1996).
4. BEYER, J., SCHWELLA, N., ZINGSEM, J., STROHSCHEER, I., SCHWANER, I., OETTLE, H., SERKE, S., HUHN, D. and SIEGERT, W., Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J. clin. Oncol., 13, 1328-1335 (1995).
5. NICHOLS, C.R. AND 13 OTHERS, Dose-intensive chemotherapy in refractory germ cell cancer - a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J. clin. Oncol., 7, 932-939 (1989).
6. RICK, O., BEYER, J., KINGREEN, D., SCHWELLA, N., KRUSCH, A., SCHLEICHER, J., KIRSCH, A., HUHN, D. and SIEGERT, W., High-dose chemotherapy in germ cell tumours: a large single centre experience. Europ. J. Cancer, 34, 1883-1888 (1998).
7. SCHWELLA, N., BEYER, J., SCHWANER, I., HEUFT, H.G., RICK, O., HUHN, D., SERKE, S. and SIEGERT, W., Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J. clin. Oncol., 14, 1114-1121 (1996).
8. SIEGERT, W. and BEYER, J., Germ cell tumors: dose-intensive therapy. Semin. Oncol., 25, 215-223 (1998).
9. SIEGERT, W., BEYER, J., STROHSCHEER, I., BAURMANN, H., OETTLE, H., ZINGSEM, J., ZIMMERMANN, R., BOKEMEYER, C., SCHMOLL, H.J. and HUHN, D., High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J. clin. Oncol., 12, 1223-1231 (1994).